Join to View Full Profile
150 Flanders RdWestborough, MA 01581
Phone+1 508-870-2222
Fax+1 207-351-2216
Dr. Jac is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2005- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2003
Maimonides Medical CenterResidency, Internal Medicine, 1992 - 1995
Wroclaw Medical UniversityClass of 1990
Certifications & Licensure
MA State Medical License 2008 - 2025
ME State Medical License 1995 - 2025
NH State Medical License 2018 - 2020
TX State Medical License 1995 - 2018
MI State Medical License 1995 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- 16 citationsPhase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.Eng Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, Quan Sing Ng, Jin Seok Ahn
Clinical Pharmacology in Drug Development. 2018-01-18 - 59 citationsVaccination of Renal Cell Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Alone or Administered in Combination With Interferon-...Robert J. Amato, William Shingler, Madusha Goonewardena, Jackie de Belin, Stuart Naylor
Journal of Immunotherapy. 2009-09-01 - 164 citationsA phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancerRobert J. Amato, J. Jac, Sarah Giessinger, Somyata Saxena, J. P. Willis
Cancer. 2009-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
